{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Biotech Finance And Investor Update With Independent Board Director Allan Shaw","slug":"biotech-finance-and-investor-update-with-independent-board-director-allan-shaw","published_at":"2026-09-14T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/biotech-finance-and-investor-update-with-independent-board-director-allan-shaw","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19779191-biotech-finance-and-investor-update-with-independent-board-director-allan-shaw.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19779191-biotech-finance-and-investor-update-with-independent-board-director-allan-shaw.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Independent Board Director and five-time public company CFO Alan Shaw returns to the show for an update on current biotech financing and the strategies needed to secure capital now. Allan explains how biotech investors price risk as the market opens back up, the importance of valuation discipline, and the financing choices that separate “available capital” from “accessible capital.” Alla...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Independent Board Director and five-time public…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3314,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/biotech-finance-and-investor-update-with-independent-board-director-allan-shaw/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/biotech-finance-and-investor-update-with-independent-board-director-allan-shaw.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}